JNJB34

Johnson & Johnson Shs Unsponsored Brazilian Depository Receipt Repr 0.0666667 Sh · BMFBOVESPA:JNJB34

97.03 BRL−3.35 −3.34%

Johnson & Johnson Shs Unsponsored Brazilian Depository Receipt Repr 0.0666667 Sh (BMFBOVESPA:JNJB34) last traded at 97.03 BRL, down 3.34% on the day. Over the past year the stock is up 44.18%. Its 52-week range is 65.65 to 102.19. It is in the Health Technology sector (Pharmaceuticals: Major).

Key statistics

Open100.37

Day range97.03 – 100.37

52-week range65.65 – 102.19

Volume16.06 K

Average volume (10 days)12.11 K

Market cap (USD)651.32 B

P/E42,186.96

EPS (TTM) (USD)0.000443

Dividend yield1.21%

Beta (1 year)−0.3978

Revenue (TTM) (USD)99.66 B

Employees140.80 K

Performance

+1.13%1 week

+6.74%1 month

+10.44%3 months

+31.28%6 months

+28.23%Year to date

+44.18%1 year

Technical reading

Bullish

Daily summary of what 11 oscillators and 15 moving averages show. See every indicator

Latest headlines

How health care is on the ballot in the midtermsSeeking Alpha · 03 Nov 2026
Most and least shorted mid- to mega-cap healthcare stocks at the end of OctoberSeeking Alpha · 03 Nov 2026
Johnson & Johnson reports 94% success rate in trial of coronary artery deviceSeeking Alpha · 01 Nov 2026
Johnson & Johnson reports lower mortality rates with Impella heart pumpsSeeking Alpha · 01 Nov 2026
J&J Reports Positive Survival And Outcomes With Impella In HrpciReuters · 01 Nov 2026
Data Show Positive Survival and Patient Outcomes with Best-Practice Impella Support in HRPCI, in Contrast to CHIP-BCIS3 Study ResultsBusinessWire · 01 Nov 2026
Ayushman Bharat Digital Mission Can Transform Healthcare Through Data, Says NITI Aayog MemberBusinessworld · 01 Nov 2026
JNJ's MedTech Segment Disappoints in Q3: Will Growth Rebound in Q4?Zacks · 30 Oct 2026

Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.